Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of 14.98% is 270% above its 5-year average of -8.80%, near the high end of its 5-year range (-50.75%–31.06%).
8.15% above its 12-month average of 13.85%.
Reported quarterly EBITDA margin; no daily interpolation. Q2 FY2026 (2026-06-30): 4.76%.
EBITDA MARGIN
14.98%
EBITDA MARGIN AVG TTM
13.85%
EBITDA MARGIN AVG 3Y
-5.85%
EBITDA MARGIN AVG 5Y
-8.80%
EBITDA MARGIN AVG 10Y
-8.56%
EBITDA MARGIN AVG 15Y
-7.10%
EBITDA MARGIN AVG 20Y
-8.37%
CURRENT VS TTM AVG
+8.15%
CURRENT VS 3Y AVG
+356.12%
CURRENT VS 5Y AVG
+270.17%
CURRENT VS 10Y AVG
+275.01%
CURRENT VS 15Y AVG
+310.99%
CURRENT VS 20Y AVG
+279.06%
OptimizeRx Corp.
Market Cap
$166.07M
EBITDA Margin
14.98%
TTM Avg
13.85%
3Y Avg
-5.85%
5Y Avg
-8.80%
Market Cap
$163.27M
EBITDA Margin
-65.55%
TTM Avg
-49.11%
3Y Avg
-55.76%
5Y Avg
-50.22%
Market Cap
$169.56M
EBITDA Margin
-18889.15%
TTM Avg
-9445.90%
3Y Avg
-9445.90%
5Y Avg
-9445.90%
Market Cap
$169.76M
EBITDA Margin
-138.09%
TTM Avg
-113.30%
3Y Avg
-81.67%
5Y Avg
-67.39%
Market Cap
$161.45M
EBITDA Margin
-416.41%
TTM Avg
-228.13%
3Y Avg
-163.44%
5Y Avg
-116.60%
Market Cap
$170.49M
EBITDA Margin
14.71%
TTM Avg
8.99%
3Y Avg
8.81%
5Y Avg
10.76%
Market Cap
$172.53M
EBITDA Margin
-83.89%
TTM Avg
-252.72%
3Y Avg
-1380.70%
5Y Avg
-1383.45%
Market Cap
$172.81M
EBITDA Margin
-144.16%
TTM Avg
-87.79%
3Y Avg
-115.19%
5Y Avg
-149.65%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| OptimizeRx Corp. (OPRX) | $166.07M | 14.98% | 13.85% | -5.85% | -8.80% |
| Quanterix Corporation (QTRX)vs › | $163.27M | -65.55% | -49.11% | -55.76% | -50.22% |
| Nkarta, Inc. (NKTX)vs › | $169.56M | -18889.15% | -9445.90% | -9445.90% | -9445.90% |
| MediWound Ltd. (MDWD)vs › | $169.76M | -138.09% | -113.30% | -81.67% | -67.39% |
| PepGen Inc. (PEPG)vs › | $161.16M | N/A | N/A | N/A | N/A |
| Coherus Oncology, Inc. (CHRS)vs › | $161.45M | -416.41% | -228.13% | -163.44% | -116.60% |
| Organogenesis Holdings Inc. (ORGO)vs › | $170.49M | 14.71% | 8.99% | 8.81% | 10.76% |
| Cue Biopharma, Inc. (CUE)vs › | $172.53M | -83.89% | -252.72% | -1380.70% | -1383.45% |
| Precision BioSciences, Inc. (DTIL)vs › | $172.81M | -144.16% | -87.79% | -115.19% | -149.65% |
| Minerva Neurosciences, Inc. (NERV)vs › | $158.40M | 4.91% | 4.91% | 4.91% | 4.91% |
Gross Margin
63.3%
EBITDA Margin
15.0%
Operating Margin
11.4%
Net Margin
4.7%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2026-06-30 | 4.76% |
| 2026-03-31 | 7.36% |
| 2025-12-31 | 31.06% |
| 2025-09-30 | 11.47% |
| 2025-06-30 | 14.60% |
| 2025-03-31 | -4.65% |
| 2024-12-31 | 14.63% |
| 2024-09-30 | -35.04% |
| 2024-06-30 | -14.22% |
| 2024-03-31 | -20.12% |
| 2023-12-31 | -34.89% |
| 2023-09-30 | -19.27% |
| 2023-06-30 | -31.73% |
| 2023-03-31 | -50.75% |
| 2022-12-31 | -2.07% |
| 2022-09-30 | -23.33% |
| 2022-06-30 | -24.00% |
| 2022-03-31 | -24.16% |
| 2021-12-31 | 5.40% |
| 2021-09-30 | 3.50% |
| 2021-06-30 | 6.59% |
| 2021-03-31 | -1.00% |
| 2020-12-31 | 10.74% |
| 2020-09-30 | 3.30% |
| 2020-06-30 | -6.09% |
| 2020-03-31 | -22.94% |
| 2019-12-31 | -24.52% |
| 2019-09-30 | -33.33% |
| 2019-06-30 | 10.21% |
| 2019-03-31 | 6.19% |
| 2018-12-31 | 0.42% |
| 2018-09-30 | 5.13% |
| 2018-06-30 | 6.43% |
| 2018-03-31 | -3.32% |
| 2017-12-31 | -3.19% |
| 2017-09-30 | -16.02% |
| 2017-06-30 | -8.31% |
| 2017-03-31 | -37.45% |
| 2016-12-31 | -12.50% |
| 2016-09-30 | -11.01% |
| 2016-06-30 | -28.82% |
| 2016-03-31 | -17.71% |
| 2015-12-31 | -16.04% |
| 2015-09-30 | 8.48% |
| 2015-06-30 | -4.57% |
| 2015-03-31 | -2.14% |
| 2014-12-31 | 7.42% |
| 2014-09-30 | -20.25% |
| 2014-06-30 | 0.28% |
| 2014-03-31 | -45.13% |
| 2013-12-31 | 0.27% |
| 2013-09-30 | 4.29% |
| 2013-06-30 | 36.44% |
| 2013-03-31 | -8.48% |
| 2012-12-31 | 22.11% |
| 2012-09-30 | -13.11% |
| 2012-06-30 | -5.60% |
| 2012-03-31 | -77.38% |
| 2011-12-31 | -226.86% |
| 2011-09-30 | -136.22% |
| 2011-06-30 | -131.35% |
| 2011-03-31 | -11.52% |
| 2010-12-31 | -1359.03% |
| 2010-09-30 | -1221.98% |
| 2010-06-30 | -5186.81% |
| 2010-03-31 | -19772.56% |
| 2009-12-31 | -2548.70% |
| 2009-09-30 | -7513.45% |
| 2009-06-30 | -9970.54% |
| 2009-03-31 | -107545.55% |
| 2008-12-31 | -6075.43% |
| 2008-09-30 | -13693.79% |
| 2008-06-30 | -1149.10% |
| 2008-03-31 | -410.95% |
